DDD vs PAYS

DDD exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health and deteriorating operational efficiency. While the current price of $2.26 sits below the Graham Number ($2.66), the company suffers from negative operating margins (-20.18%) and declining revenue growth (-4.30%). The stark contrast between the positive ROE and negative ROA suggests a precarious capital structure or non-operating gains masking core business failure. With a 5-year price decline of over 90% and a bearish technical trend, the stock appears to be a value trap.

PAYS exhibits a stable financial foundation with a Piotroski F-Score of 6/9, but it is currently trading at a severe premium to its deterministic value (Graham Number: $1.60, Intrinsic Value: $0.91). While revenue growth is explosive at 45.8%, this has not yet translated into bottom-line earnings growth, which remains slightly negative (-3.60%). The stock has experienced a parabolic 1-year run (+179.4%), leading to a high trailing P/E of 44.92, though the Forward P/E of 15.07 suggests significant expected earnings acceleration. Overall, the company is fundamentally healthy but valuationally overextended.